Epica International, a global innovator in veterinary and human diagnostic imaging systems, today announced a new strategic partnership with Catalyst MedTech, a nationally recognized leader in medical imaging service and support. The partnership strengthens Epica’s commitment to delivering fast, responsive, and expert service to its growing base of U.S. customers.
Catalyst MedTech brings decades of experience in the diagnostic imaging field and a proven track record of providing high-quality support across a wide range of imaging technologies. Together, Epica and Catalyst will offer a robust, scalable service platform that reduces downtime, speeds response times, and enhances customer satisfaction across both Epica Human Health and Imaginalis Imaging, Epica’s veterinary division.
“We’re excited to partner with Catalyst to continue raising the bar on service,” said Joe Soto, CEO of Epica International. “Our customers rely on us not only for imaging innovation but for dependable, high-touch support. This partnership allows us to scale our service capabilities while keeping the customer experience personal and responsive.”
“As the only independent, ISO-certified partner delivering OEM-grade service for nuclear medicine, molecular imaging and computed tomography systems, Catalyst MedTech brings unmatched expertise and nationwide reach – ensuring Epica customers receive elite-level support, faster response, and long-term value across every system.” said Marty Shirley, President and CEO of Catalyst MedTech.
This growing partnership reflects Epica’s long-term commitment to continual improvement, customer satisfaction, and operational excellence. Both companies are also excited about the potential to expand the scope of this collaboration to support future innovation and delivery.